Valsartan Lawyers

Valsartan Lawsuit

Manufacturers Announce Valsartan Recall After Batches of Drug Contaminated with Cancer-Causing Substances

Several drug companies that manufacture generic Valsartan have recalled the medication after discovering that it may have been contaminated in the manufacturing plants where it was being produced. Batches of Valsartan produced by the Chinese company Zhejiang Huahai Pharmaceuticals and the India company Hetero Labs Limited were contaminated with N-nitrosodimethylamine (NDMA).

The companies impacted by this contamination include:

• Actavis
• A-S Medication Solutions
• AvKARE
• Bryant Rank Prepack
• Camber Pharmaceuticals
• Hereto Labs, Inc.
• HJ Harkins Company
• Major Pharmaceuticals
• Mylan Pharmaceuticals
• Northwind Pharmaceuticals
• NuCare Pharmaceuticals
• Preferred Pharmaceuticals
• Prinston Pharmaceutical
• RemedyRepack Inc.
• Solco Healthcare
• Teva Pharmaceuticals
• Torrent Pharmaceuticals Limited

NDMA is a known carcinogen and even short-term exposure can cause liver damage, including liver fibrosis and scarring. Long-term exposure increases the risk of liver, kidney and lung tumors. NDMA is not produced or commercially used in the United States, except for research purposes.

Symptoms of NDMA Overexposure from Contaminated Valsartan

Symptoms of NDMA exposure include headaches, fever, nausea, jaundice, vomiting, abdominal cramps, dizziness, enlarged liver and impaired function of the liver, kidneys and lungs.

About Valsartan

Valsartan is an angiotensin II receptor blocker (ARB) used in the treatment of high blood pressure, heart failure and recent heart attacks.

If you have experienced serious health issues after taking Valsartan, promptly consult your physician for an evaluation.

If you have developed liver, kidney, stomach or intestinal cancer after taking Valsartan, you may be entitled to compensation. You should act immediately to contact an attorney experienced in matters involving defective pharmaceuticals.